Cargando…

Prevalence of QTc Prolongation in Patients with Parkinson’s Disease. Assessment of the Effects of Drugs, Clinical Risk Factors and Used Correction Formula

Background: Parkinson’s disease (PD) is a possible risk factor for corrected QT interval (QTc) prolongation. PD patients frequently take QTc-prolonging drugs. The aim of the study was to assess the prevalence of QTc prolongation in PD and the influence of drugs and other potential risk factors on th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malkiewicz, Jakub J., Malkiewicz, Maciej, Siuda, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037693/ https://www.ncbi.nlm.nih.gov/pubmed/33807236 http://dx.doi.org/10.3390/jcm10071396

Ejemplares similares

Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
por: Gupta, Anunay, et al.
Publicado: (2020)

Prevalence and Risk Factors of QTc Prolongation During Pregnancy
por: Luo, Chaodi, et al.
Publicado: (2022)

Problems with Bazett QTc correction in paediatric screening of prolonged QTc interval
por: Andršová, Irena, et al.
Publicado: (2020)

The corrected QT (QTc) prolongation in hyperthyroidism and the association of thyroid hormone with the QTc interval
por: Lee, Ye Seung, et al.
Publicado: (2015)

QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications
por: Fernandes, Flávia Medeiros, et al.
Publicado: (2018)

Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients
por: Ansermot, Nicolas, et al.
Publicado: (2019)

QTc prolongation assessment in anticancer drug development: clinical and methodological issues
por: Curigliano, G, et al.
Publicado: (2009)

Prevalence and Risk Factors of Prolonged QTc Interval among Chinese Patients with Type 2 Diabetes
por: Li, Xiang, et al.
Publicado: (2012)

The Prevalence, Risk Factors and Clinical Correlates of QTc Prolongation in Chinese Hospitalized Patients With Chronic Schizophrenia
por: Cao, Haiyan, et al.
Publicado: (2021)

The Challenges of Predicting Drug-Induced QTc Prolongation in Humans
por: Valentin, Jean-Pierre, et al.
Publicado: (2022)

Influence of heart rate correction formulas on QTc interval stability
por: Andršová, Irena, et al.
Publicado: (2021)

Paroxetine‐induced QTc prolongation
por: Otsuka, Yuji
Publicado: (2017)

Psychotropic Drugs and Prolonged QTc Interval: Does it Really that Matter?
por: Naguy, Ahmed
Publicado: (2016)

Levofloxacin‐Induced QTc Prolongation Depends on the Time of Drug Administration
por: Kervezee, L, et al.
Publicado: (2016)

Ketamine-induced QTc interval prolongation
por: Singh, Tejinder S. Swaran, et al.
Publicado: (2017)

Hydroxychloroquine: QTc prolongation: case report.
Publicado: (2020)

Evaluation of the potential for QTc prolongation with avelumab
por: Vugmeyster, Yulia, et al.
Publicado: (2019)

Ticagrelor-Induced Prolongation of the QTc Interval
por: Ray, Avik, et al.
Publicado: (2019)

An overview of QTc Prolongation with antipsychotics and antidepressants
por: Bhandari, Samrat Singh, et al.
Publicado: (2022)

The Effect of COVID-19 on QTc Prolongation
por: Alsallamin, Isaac, et al.
Publicado: (2022)

Commentary on: “Levofloxacin‐Induced QTc Prolongation Depends on the Time of Drug Administration”
por: Garnett, C, et al.
Publicado: (2016)

Multiple drugs: QTc prolongation and torsades de pointes: case report
Publicado: (2021)

Multiple drugs: Off label use and QTc prolongation: case report
Publicado: (2021)

Multiple drugs: QTc prolongation and off-label use: case report
Publicado: (2021)

Assessment of Interspecies Differences in Drug-Induced QTc Interval Prolongation in Cynomolgus Monkeys, Dogs and Humans
por: Dubois, V. F. S., et al.
Publicado: (2015)

Content Validation of an Algorithm for the Assessment, Management and Monitoring of Drug-Induced QTc Prolongation in the Psychiatric Population
por: Zolezzi, Monica, et al.
Publicado: (2021)

Assessment of Drug-Induced QTc Prolongation in Mental Health Practice: Validation of an Evidence-Based Algorithm
por: Zolezzi, Monica, et al.
Publicado: (2023)

A thorough QTc study demonstrates that olmesartan medoxomil does not prolong the QTc interval
por: Mendell, Jeanne, et al.
Publicado: (2015)

Baseline-Corrected QT (QTc) Interval Is Associated with Prolongation of QTc during Severe Hypoglycemia in Patients with Type 2 Diabetes Mellitus
por: Cha, Seon-Ah, et al.
Publicado: (2016)

Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study
por: Ali, Zahid, et al.
Publicado: (2020)

Associations of Prolonged QTc in Sickle Cell Disease
por: Indik, Julia H., et al.
Publicado: (2016)

Evaluation of QTc prolongation and dosage effect with citalopram
por: McClelland, Justine, et al.
Publicado: (2016)

QTc Prolongation in Patients Receiving Triazoles and Amiodarone
por: Cook, Katherine, et al.
Publicado: (2017)

QTc interval prolongation, COVID-19 and chloroquine
por: Wiwanitkit, V.
Publicado: (2020)

QTc Prolongation in the Critically Ill: Tread with Caution!
por: Elangovan, Ashok
Publicado: (2020)

No QTc Prolongation in Girls and Women with Turner Syndrome
por: Noordman, Iris D, et al.
Publicado: (2020)

Hydroxychloroquine: QTc prolongation: 2 case reports
Publicado: (2021)

Tozinameran: Myocarditis with QTc prolongation: case report
Publicado: (2022)

Nilotinib: QTc prolongation: 2 case reports
Publicado: (2021)

PONV management in patients with QTc prolongation on the EKG
por: Soghomonyan, S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7raafopgthdl780i1o6sa5lrsg